Today: 22 May 2026
Broadcom stock nudges higher after Wolfe upgrade puts Google TPU ramp back in play
30 January 2026
1 min read

Broadcom stock nudges higher after Wolfe upgrade puts Google TPU ramp back in play

New York, January 30, 2026, 10:43 (EST) — Regular session

  • Broadcom shares rose roughly 0.3% mid-morning, standing out amid a wider slump in chip stocks
  • Wolfe Research has upgraded AVGO to Outperform, assigning a $400 price target amid Google’s TPU scale-up
  • Broadcom’s upcoming earnings report is due after the close on March 4

Shares of Broadcom Inc. ticked up roughly 0.3% to $331.71 in mid-morning trading on Friday. Wolfe Research upgraded the stock to Outperform, assigning a $400 price target. Analyst Chris Caso noted in a summary, “we can no longer ignore” Broadcom’s growth and strength in Google’s tensor processing units. TipRanks

Timing is crucial as investors wrestle with distinguishing signal from noise in the custom AI chip market, where demand often depends on just a few clients and major product cycles. Even a straightforward upgrade can shift the tape, despite little movement in the stock itself.

Broadcom bucked the trend. The VanEck Semiconductor ETF slipped roughly 1.7%, the Nasdaq-100 tracker QQQ dropped about 0.7%, and the SPDR S&P 500 ETF edged down close to 0.3%.

Wolfe’s checks with suppliers and customers indicate Google’s TPU shipments could hit around 7 million units annually by 2028. The firm highlighted that Google opening its TPUs to external clients might provide serious competition to Nvidia’s GPUs. Broadcom is seen as poised to grab a sizable chunk of the custom silicon market. Wolfe also boosted its AI ASIC revenue forecast for Broadcom to roughly $44 billion in 2026 and $78.4 billion in 2027, the report said.

TPU stands for tensor processing unit, Google’s custom chip designed specifically for training and running AI models. ASIC, or application-specific integrated circuit, refers to a chip tailored for a specific task or client, unlike a general-purpose processor.

The day showed a sharp divide. Nvidia slipped roughly 0.3%, while Advanced Micro Devices tumbled nearly 3.9% during that period.

Broadcom’s AI-driven growth has delivered mixed signals to investors. Back in December, the company projected strong quarterly revenue, fueled by robust demand for its AI chips. Yet shares slipped in after-hours trading when CFO Kirsten Spears cautioned that gross margins would shrink by “about 100 basis points” sequentially. Reuters

The market’s still caught in that tug-of-war. Bulls are hunting for proof that orders are expanding past just a handful of hyperscalers and that networking demand is tracking the compute expansion. Skeptics, meanwhile, keep circling back to worries over mix-driven margin pressure and the chance customers might hit pause.

The sector faces a straightforward concentration risk. Should TPU rollouts delay, cloud clients extend their spending cycles, or rivals alter the pace of custom-chip victories, price targets won’t last. This space tends to reprice fast.

Broadcom announced during its last earnings call it will release first-quarter fiscal 2026 results after markets close on Wednesday, March 4. Investors will focus on any news about AI-related orders, customer ramp-ups, and whether the company revises its margin outlook.

Stock Market Today

  • NYSE's Martin Questions Nasdaq Rules Attracting SpaceX IPO
    May 22, 2026, 9:22 AM EDT. Lynn Martin, President of the New York Stock Exchange (NYSE), criticized some of the Nasdaq's listing rules used to attract SpaceX's public offering as "questionable." Speaking on Bloomberg Surveillance, Martin emphasized that market integrity should not be compromised for competitive gains between stock exchanges. She noted 2023 has been a strong year for initial public offerings (IPOs) across sectors and affirmed the NYSE's commitment to bringing more companies public. Martin's remarks highlight ongoing debates over regulatory standards and competitive practices in the IPO market.

Latest articles

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

22 May 2026
Akari Therapeutics shares more than doubled in premarket trading Friday after its lead cancer drug showed positive preclinical results in KRAS-mutated pancreatic cancer models and the company announced a $5.5 million private placement. The stock was quoted at $10.15, up from Thursday’s $5.14 close. Akari plans to start Phase 1 human trials of AKTX-101 by mid-2027. The company reported $2.8 million in cash at March 31.
BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

22 May 2026
Canaccord Genuity reaffirmed a Buy rating on Bank of Montreal ahead of its May 27 earnings report. BMO shares closed May 21 at C$220.06, near a 52-week high and up 23.5% year-to-date. The bank recently agreed to sell C$14.5 billion in loan and lease assets to Stonepeak, expecting a CET1 ratio boost but a C$900 million after-tax charge. Analyst consensus remains mixed, with most holding or selling.
Atmos Energy’s run in Texas faces new Wall Street target cut

Atmos Energy’s run in Texas faces new Wall Street target cut

22 May 2026
Morgan Stanley lowered its Atmos Energy price target to $183 from $195, maintaining an Equalweight rating. The move follows Atmos’ recent increase in its 2026 earnings outlook and annual dividend. Atmos shares closed at $177.46 on Thursday. Texas remains central to Atmos’ growth and regulatory strategy, with 65% of its rate base in the state.
Silver price today: XAG/USD tumbles near $100 as Warsh Fed pick jolts metals
Previous Story

Silver price today: XAG/USD tumbles near $100 as Warsh Fed pick jolts metals

AT&T stock price rises again: $45 billion return plan, fiber deals and what comes next
Next Story

AT&T stock price rises again: $45 billion return plan, fiber deals and what comes next

Go toTop